CPIX · Cumberland Pharmaceuticals Inc

$7.65 +0.15 (+2.00%) At close · Aug 21

Market Cap

$114.62M

14.98M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized

$5,000,000

as of 2026-07-13 · from 8-K (reviewed)

Program Announced	Authorized	Remaining	As of	Runs Through	Source
2026-07-13	$5,000,000	—	—	—	8-K , filed 2026-07-13

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2026-06-30 YTD	$61,001	—	—	10-Q, filed 2026-08-07
2025-12-31	$263,478	58,947	$4.47	10-K, filed 2026-03-09
2024-12-31	$579,049	339,200	$1.71	10-K, filed 2026-03-09
2023-12-31	$740,533	402,143	$1.84	10-K, filed 2025-03-07
2022-12-31	$1,053,042	—	—	10-K, filed 2024-03-13
2021-12-31	$1,386,849	—	—	10-K, filed 2023-03-13
2020-12-31	$1,851,526	—	—	10-K, filed 2022-03-11
2019-12-31	$3,494,921	—	—	10-K, filed 2022-03-11
2018-12-31	$2,879,426	—	—	10-K, filed 2021-03-12
2017-12-31	$3,724,375	—	—	8-K, filed 2020-12-10
2016-12-31	$2,520,715	—	—	10-K, filed 2019-03-12
2015-12-31	$5,338,967	—	—	10-K, filed 2018-03-09
2014-12-31	$4,315,444	—	—	10-K, filed 2017-03-13
2013-12-31	$4,800,908	—	—	10-K, filed 2016-03-14
2012-12-31	$8,086,594	—	—	10-K, filed 2015-03-09
2011-12-31	$4,247,440	—	—	10-K, filed 2014-03-11
2010-12-31	$4,846,791	—	—	10-K, filed 2013-03-12
2009-12-31	$27,295,808	—	—	10-K, filed 2012-03-07

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2026-06-30	$0 Δ	—	—	10-Q, filed 2026-08-07
2026-03-31	$61,001	—	—	10-Q, filed 2026-05-08
2025-12-31	$0 Δ	—	—	10-K, filed 2026-03-09
2025-09-30	$10,439 Δ	—	—	10-Q, filed 2025-11-07
2025-06-30	$7,171 Δ	—	—	10-Q, filed 2026-08-07
2025-03-31	$245,868	—	—	10-Q, filed 2026-05-08
2024-12-31	$98,383 Δ	—	—	10-K, filed 2026-03-09
2024-09-30	$98,815 Δ	—	—	10-Q, filed 2025-11-07
2024-06-30	$134,246 Δ	—	—	10-Q, filed 2025-08-08
2024-03-31	$247,605	—	—	10-Q, filed 2025-05-09
2023-12-31	$188,970 Δ	—	—	10-K, filed 2025-03-07
2023-09-30	$201,653 Δ	—	—	10-Q, filed 2024-11-08

Key facts CIK 1087294 CUSIP 230770109 13F (30d) 32 filings 32 filers Visit website Investor relations